Specjalistyczne Gabinety Sp. z o.o.
- Address
- lock Available on a paid plan
Neurology and Nervous System Diseases
At Specjalistyczne Gabinety Sp. z o.o. in Cracow, the clinical trial portfolio is strongly centered on migraine and other neurological disorders. Research here includes studies aimed at improving prevention and symptom control, especially for children, adolescents, and adults living with frequent headaches or related conditions.
- Studies in chronic migraine, episodic migraine, and menstrual migraine
- Trials evaluating new options for migraine prevention and long-term tolerability
- Research focused on insomnia disorder and broader neurologic symptom management
This area reflects a clear effort to test new therapies that may help reduce headache burden and improve daily functioning for people affected by persistent nervous system conditions.
Movement Disorders and Spasticity
The site also supports research in musculoskeletal diseases and neurologic movement disorders, with studies addressing abnormal muscle tone, involuntary movements, and functional limitations after cerebral palsy, stroke, or traumatic brain injury.
- Lower limb spasticity and upper limb spasticity in children and adults
- Cervical dystonia and dyskinesia due to cerebral palsy
- Trials designed to assess whether new treatments can improve movement control and daily comfort
These studies aim to improve treatment effectiveness for people with chronic motor symptoms, including patients seen through the Neurologia department.
Neuromuscular and Immune System Diseases
Clinical research at this site includes conditions where the nervous system and immune system overlap, such as generalized myasthenia gravis. The trials are focused on evaluating whether new treatment approaches can better control muscle weakness and support longer-term disease management.
- Generalized myasthenia gravis studies
- Evaluation of treatment safety, tolerability, and sustained benefit
- Research into self-administration and patient-friendly treatment use
This work helps expand options for people with chronic immune-mediated neurologic disease, with an emphasis on practical treatment use in everyday care.
Oncology and Cardiovascular Diseases
The site contributes to research in neoplasms and cardiovascular diseases, including studies in prostate cancer, non-small cell lung cancer, and prevention of cancer-associated thrombosis. These trials are designed to improve treatment outcomes and reduce serious complications linked to cancer care.
- Metastatic castration-sensitive prostate cancer
- Early-stage non-small cell lung cancer
- Cancer-associated thrombosis prevention during cancer treatment
This research broadens the site’s portfolio beyond neurology and reflects interest in testing therapies that may improve survival, safety, and quality of care for patients with complex oncology needs.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 4 of 6 therapeutic areas and 15 of 20 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 3 by active trials.
- 1AbbVie Deutschland GmbH & Co. KG4active
lock +2 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1AbbVie Deutschland GmbH & Co. KG5trials
lock +4 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Specjalistyczne Gabinety Sp. z o.o.
lock Showing 1 of 22 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Multicenter, Open-label, Extension Study to Evaluate the Long-term Safety and Tolerability of Atogepant in Pediatric Subjects 6 to 17 years of age with Migraine | AbbVie Deutschland GmbH & Co. KG | Phase III | Recruiting | Dec 2023 | — |
IMP list
lock Showing 1 of 20 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Atogepant | 4 | Unknown | 2021-08-16 | 2025-06-23 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.